The New Biotechnological Medication 'FarGALS' and Its Antimicrobial Properties

摘要

The purpose of this work was to study the antimicrobial activity of a new medication "FarGALS" and to determine the prospects of its clinical application to treat nosocomial infections. It was established that "FarGALS" possessed pronounced antimicrobial activity against a wide spectrum of pathogenic microorganisms, such as Gram-positive, Gram-negative, nonspore-forming and spore-forming bacteria, as well as Candida spp. and H. pylori. It has been concluded that the given medication can be used as an antimicrobial agent in the treatment and prevention of various purulent and inflammatory processes, mycosis and other infectious diseases.